Cameron Coulby1, Francesca Reyes Domingo1, Joanne Hiebert2, Susan G Squires1. 1. Centre for Immunization and Respiratory Infectious Diseases, Public Health Agency of Canada, Ottawa, ON. 2. National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB.
Abstract
BACKGROUND: The Public Health Agency of Canada (PHAC) has conducted enhanced measles surveillance since 1998, the year endemic measles transmission was eliminated in Canada. The objective of this annual national measles surveillance report is to provide an epidemiologic summary of measles activity reported in Canada for 2019 in order to provide evidence to support the continued verification of Canada's measles elimination status. METHODS: Measles surveillance data are housed in the Canadian Measles and Rubella Surveillance System (CMRSS) database. Descriptive analyses of demographics and risk factors were performed. Outbreak characteristics were summarized and genotypic analyses conducted. Surveillance, laboratory and vaccine coverage data for 2019 were used to assess Canada's status against the Pan American Health Organization (PAHO) essential criteria for the verification of measles elimination. RESULTS: In 2019, 113 measles cases were reported in Canada (crude incidence rate of 3.0 cases per 1,000,000 population). Of these cases, 42 (37%) were imported into Canada, and of the imported cases, 12 (29%) resulted in further transmission. Infants younger than one year had the highest age-specific incidence rate at 13.1 cases per 1,000,000 population. Only 29% of cases had one or more documented doses of measles-containing vaccine. One-fifth (19%) of cases were hospitalized; no deaths were reported. Genotype information was available for 100% of outbreaks reported in 2019 and 90% of non-outbreak-related measles cases; of cases with genotype information available, 27% were B3 and 73% were D8. CONCLUSION: Despite meeting/partially meeting only three out of four of PAHO's essential criteria for measles elimination status, there is no evidence that endemic measles transmission has been reestablished in Canada.
BACKGROUND: The Public Health Agency of Canada (PHAC) has conducted enhanced measles surveillance since 1998, the year endemic measles transmission was eliminated in Canada. The objective of this annual national measles surveillance report is to provide an epidemiologic summary of measles activity reported in Canada for 2019 in order to provide evidence to support the continued verification of Canada's measles elimination status. METHODS: Measles surveillance data are housed in the Canadian Measles and Rubella Surveillance System (CMRSS) database. Descriptive analyses of demographics and risk factors were performed. Outbreak characteristics were summarized and genotypic analyses conducted. Surveillance, laboratory and vaccine coverage data for 2019 were used to assess Canada's status against the Pan American Health Organization (PAHO) essential criteria for the verification of measles elimination. RESULTS: In 2019, 113 measles cases were reported in Canada (crude incidence rate of 3.0 cases per 1,000,000 population). Of these cases, 42 (37%) were imported into Canada, and of the imported cases, 12 (29%) resulted in further transmission. Infants younger than one year had the highest age-specific incidence rate at 13.1 cases per 1,000,000 population. Only 29% of cases had one or more documented doses of measles-containing vaccine. One-fifth (19%) of cases were hospitalized; no deaths were reported. Genotype information was available for 100% of outbreaks reported in 2019 and 90% of non-outbreak-related measles cases; of cases with genotype information available, 27% were B3 and 73% were D8. CONCLUSION: Despite meeting/partially meeting only three out of four of PAHO's essential criteria for measles elimination status, there is no evidence that endemic measles transmission has been reestablished in Canada.
Authors: Carlos Castillo-Solórzano; Susan E Reef; Ana Morice; Jon Kim Andrus; Cuauthémoc Ruiz Matus; Gina Tambini; Socorro Gross-Galiano Journal: J Infect Dis Date: 2011-09-01 Impact factor: 5.226
Authors: Alya Dabbagh; Rebecca L Laws; Claudia Steulet; Laure Dumolard; Mick N Mulders; Katrina Kretsinger; James P Alexander; Paul A Rota; James L Goodson Journal: MMWR Morb Mortal Wkly Rep Date: 2018-11-30 Impact factor: 17.586
Authors: Shelly Bolotin; Alberto Severini; Todd Hatchette; Elizabeth McLachlan; Rachel Savage; Stephanie L Hughes; John Wang; Shelley L Deeks; Sarah Wilson; Marc Brisson; Scott A Halperin; Jonathan Gubbay; Tony Mazzulli; Bouchra Serhir; Brian J Ward; Natasha Crowcroft Journal: Hum Vaccin Immunother Date: 2019-07-16 Impact factor: 3.452
Authors: Selma Osman; Natasha Crowcroft; Elizabeth McLachlan; Todd Hatchette; Carol Perez-Iratxeta; Eugene Joh; James Wright; Scott A Halperin; Shelley Deeks; Sarah Wilson; Sarah Buchan; Brian Ward; Jonathan Gubbay; Marc Brisson; Bouchra Serhir; Alberto Severini; Shelly Bolotin Journal: Vaccine Date: 2022-04-28 Impact factor: 4.169